GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (ASX:AVR) » Definitions » 3-Year FCF Growth Rate

Anteris Technologies (ASX:AVR) 3-Year FCF Growth Rate : -12.40% (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies 3-Year FCF Growth Rate?

Anteris Technologies's Free Cash Flow per Share for the six months ended in Dec. 2023 was A$-1.74.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -12.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 11.70% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Anteris Technologies was 30.80% per year. The lowest was -41.80% per year. And the median was 12.10% per year.


Competitive Comparison of Anteris Technologies's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Anteris Technologies's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Anteris Technologies's 3-Year FCF Growth Rate falls into.



Anteris Technologies 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Anteris Technologies  (ASX:AVR) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Anteris Technologies 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies (ASX:AVR) Business Description

Traded in Other Exchanges
Address
Level 3, 9 Sherwood Road, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.

Anteris Technologies (ASX:AVR) Headlines

No Headlines